Author

Olav Engebraaten

Oslo University HospitalORCID 0000-0002-0986-6957Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Eivind Valen EgelandiD· 2 shared Gordon Brent MillsiD· 2 shared Mads Haugland HaugeniD· 2 shared Allison CreasoniD· 1 shared Alvaro Köhn‐LuqueiD· 1 shared Arnoldo FrigessiiD· 1 shared Cameron WatsoniD· 1 shared Chloé Beate SteeniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eivind Valen EgelandORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 9, 2025

Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response

Maria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland…·Mads Haugland Haugen

This study examines how the spatial organization of the tumor-immune microenvironment changes during treatment in ER-positive breast cancer and links these changes to clinical response.

DOI 10.1101/2025.10.09.681336

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintSep 7, 2023

Explainable Machine Learning Reveals the Role of the Breast Tumor Microenvironment in Neoadjuvant Chemotherapy Outcome

Youness Azimzade, Mads Haugland Haugen, Xavier Tekpli…·Alvaro Köhn‐Luque

The paper uses scRNA-seq and explainable machine learning to analyze how tumor microenvironment cell types affect neoadjuvant chemotherapy outcomes in breast cancer.

4 citations

humanscRNA-seq

𝕏 PostBluesky